Highlights
NASDAQ: GWPH       Gw Pharma ADR
Last Price Today's Change   Day's Range   Trading Volume
119.52   +2.78 (2.38%)  116.50 - 119.67  134,098

Overview

Avg Volume (4 weeks):0
4 Weeks Range:113.61 - 123.34
52 Weeks Range:74.05 - 137.882
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

GW Pharmaceuticals plc is a biopharmaceutical company focused on developing and commercializing therapeutics from its cannabinoid product platform in a range of disease areas. The Company's lead cannabinoid product candidate is Epidiolex, which is a liquid formulation of pure plant-derived cannabidiol (CBD). The Company offers Sativex (nabiximols), which is indicated for the treatment of spasticity due to multiple sclerosis (MS). The Company operates through three segments: Commercial, Sativex Research and Development, and Pipeline Research and Development. The Commercial segment distributes and sells the Company's commercial products. The Sativex Research and Development segment seeks to maximize the potential of Sativex through the development of new indications. The Pipeline Research and Development segment seeks to develop cannabinoid medications other than Sativex across a range of therapeutic areas using its cannabinoid technology platform.

  Be the first to like this.
 


 

4720  2281  573  751 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 CSQ 11.43+0.02 
 BNCL 16.95+0.35 
 GALT 3.129-0.141 
 BBRY 9.190.00 
 NUGT 7.765-0.405 
 X 23.297-7.813 
 TWTR 15.981+1.321 
 BAC 24.13+0.15 
 SPY 239.34+0.79 
 EEM 40.08-0.12 
Partners & Brokers